SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IPCA Laboratories acquires oral solid dosage formulations unit in Pithampur

01 Oct 2014 Evaluate

IPCA Laboratories, a Mumbai-based drugmaker, has acquired as a going concern on slump sale basis the high potency oral solid dosage formulations manufacturing unit situated at sector III, Pithampur, Dhar (Madhya Pradesh). The acquisition consisting of its leasehold land admeasuring 40,000 square meters together with buildings admeasuring 9,523 square meters standing thereon along with its plant and machineries, product dossiers and registrations, intellectual property rights belonging to the said manufacturing unit, etc.

Together with its employees from Alpha Laboratories for a consideration of Rs 71.71 crore inclusive of non compete fees but excluding stamp duty, transfer charges and registration fees payable for effectively transferring the said manufacturing unit in the name of the company. The acquisition of this manufacturing unit will help the company in forward integrating the hormonal APIs being manufactured by the company at its manufacturing unit situated at Nandesari with hormonal formulations for the world market.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1572.00 28.05 (1.82%)
06-May-2026 15:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.75
Dr. Reddys Lab 1307.35
Cipla 1365.25
Zydus Lifesciences 940.00
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×